Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 283-291

  Phillips, C ^a   Murugasu, G ^b   Owens, D ^a   Collins, P ^c   Johnson, A ^c   Tomkin, G H ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Cholesteryl ester transfer protein; Chylomicrons; Lecithin:cholesterol acyltransferase; Non insulin dependent diabetes; Postprandial lipoproteins; Very low density lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CHYLOMICRON; GLUCOSE; INSULIN; LIPOPROTEIN; METFORMIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SULFONYLUREA; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

AGED; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; EATING; FASTING; FEMALE; GLYCOPROTEINS; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0033959286     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00275-0     Document Type: Article

References (43)

1. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in diabetic subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339:1998;229-234.
2. The Diabetes Control and Complications Trial Research Group. Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med 1993;329:977-986.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33), Lancet 1998;352:837-853.
4. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyashi S., Kojima Y., Furuyoshi N., Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomised prospective 6-year study. Res. Clin. Pract. 28:1995;103-117.
5. Hadden D.R., Patterson C.C., Atkinson A.B., Kennedy L., Bell P.M., McCance D.R., Weaver J.A. Macrovascular disease and hyperglycaemia in type 2 diabetes mellitus: the Belfast Study. Diabet. Med. 14:1997;663-672.
6. Balkau B., Shipley M., Jarrett R.J., Pyorala K., Pyorala M., Forhan A., Eschwege E. High blood glucose concentration is a risk factor for mortality in middle-aged non-diabetic men. 20-year follow-up in the Whitehall study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 21:1998;360-367.
7. Stampfer J.M., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., Hennekens C.H. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276:1996;882-888.
8. Alaupovic P., Mack W.J., Knight-Gibson C., Hodis H.N. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from controlled clinical trial. Arterioscler. Thromb. Vasc. Biol. 17:1997;715-722.
9. Karpe F., Steiner G., Uffelman K., Olivercrona T., Hamsten A. Postprandial lipoproteins and the progression of coronary atherosclerosis. Atherosclerosis. 106:1994;83-97.
10. Tkac I., Kimball B.P., Lewis G., Ufferman K., Steiner G. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler. Thromb. Vasc. Biol. 17:1997;3633-3638.
11. Sakata K., Narimasa M., Shirotani M., Yoshida H., Takada Y., Takada A. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis. 136:1998;225-2314.
12. Curtin A., Deegan P., Owens D., Collins P., Johnson A., Tomkin G.H. Alterations in apolipoprotein B-48 in the post-prandial state in non-insulin-dependent diabetes. Diabetologia. 37:1994;1259-1264.
13. Curtin A., Deegan P., Owens D., Collins P., Johnson A., Tomkin G.H. Intestinally-derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia. Acta Diabetol. 32:1995;244-250.
14. Curtin A., Deegan P., Owens D., Collins P., Johnson A., Tomkin G.H. Elevated triglyceride-rich lipoproteins in diabetes: a study of apolipoprotein B48. Acta Diabetol. 33:1996;205-210.
15. Taggart C., Gibney J., Owens D., Collins P., Johnson A., Tomkin G.H. The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes. Diabet. Med. 14:1997;1051-1058.
16. Cummings M.H., Watts G.F., Umpleby A.M., Hennessy T.R., Naoumova R., Slavin B.M., Thompson G.R., Sonksen P.H. Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM. Diabetologia. 38:1995;955-967.
17. Cummings M.H., Watts G.F., Umpleby A.M., Hennessy T.R., Kelly J.M., Jackson N.C., Sonksen P.H. Acute hyperinsulinaemia decreases the hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM. Diabetes. 44:1995;1059-1065.
18. Malmstrom R., Packard C.J., Caslake M., Bedford D., Stewart P., Yki-Jarvinen H., Shepherd J., Taskinen M.-R. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 40:1997;454-462.
19. Taskinen M.-R. Insulin resistance and lipoprotein metabolism. Curr. Opin. Lipidol. 6:1995;153-160.
20. Chen Y.-D.I., Facchini F., Landau, Hollenbeck C.B., Reaven G.M. Plasma post-heparin lipoprotein lipase activity is decreased in normal individuals who are resistant to insulin-mediated glucose uptake. Endocrinol. Metab. 1:1994;153-158.
21. Knudsen P., Eriksson J., Lahdenperra S., Kahri J., Groop L., Taskinen M.-R. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia. 38:1995;344-350.
22. O'Meara N., Devery R., Owens D., Collins P., Johnson A., Tomkin G.H. Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models. Diabetologia. 34:1991;139-143.
23. Feingold KR, Wilson DE, Wood LC, Kwong LK, Moser AH, Grunfeld C. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine, Metabolism 1994;450-454.
24. Gleeson A., Owens D., Collins P., Johnson A., Tomkin G.H. The effect of diabetes on intestinally derived lipoproteins in the rat. Ir. J. Med. Sci. 167(Suppl 3):1998;2.
25. Gylling H., Miettinen T.A. Cholesterol absorption, synthesis and LDL metabolism in NIDDM. Diabetes Care. 20:1997;90-95.
26. Griffin M., Frazer A., Collins P., Johnson A., Owens D., Tomkin G.H. Cellular cholesterol synthesis - The relationship to post-prandial glucose and insulin. Atherosclerosis. 138:1998;313-318.
27. Tall A., Sammett D., Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins during alimentary lipaemia. J. Clin. Invest. 77:1986;1163-1172.
28. Bagdade J.D., Lane J.T., Subbaiah P.V., Otto M.E., Ritter M.C. Accelerated cholesteryl ester transfer in non insulin-dependent diabetes mellitus. Atherosclerosis. 104:1993;69-77.
29. Bhatnagar D., Durrington P.N., Kumar S., Mackness M.L., Boulton A.J.M. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to low density lipoproteins in patients with non-insulin-dependent diabetes mellitus. Diabet. Med. 13:1996;139-144.
30. Jones R.J., Owens D., Brennan C., Collins P.B., Johnson A.H., Tomkin G.H. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins AI and AII. Atherosclerosis. 119:1996;151-157.
31. Passarelli M., Catanozi S., Nakandakare E.R., Rocha J.C., Morton R.E., Shimabukuro A.F.M., Quintao E.C.R. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and in vitro glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo B-containing lipoproteins. Diabetologia. 40:1997;1085-1093.
32. Havel R.A., Eder H.M., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345.
33. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
34. Karpe F., Hamsten A. Determination of apo B48 and B100 in triglyceride-rich lipoproteins by sodium dodecyl sulphate polyacrylamide gel electrophoresis. J. Lipid Res. 35:1994;1311-1317.
35. Channon K.M., Clegg R.J., Bhatnagar D., Ishola M., Arrol S., Durrington P.N. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis. 80:1990;217-220.
36. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals; does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 263:1990;2893-2898.
37. Coppack S.W. Postprandial lipoproteins in non-insulin-dependent diabetes mellitus. Diabet. Med. 14:1997;S67-S74.
38. Bruno G., Cavallo-Perin P., Bargero G., Borra M., D'Errico N., Pagano G. Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study. Diabet. Med. 15:1998;304-307.
39. Lewis G.F., O'Meara N.M., Cavana V.G., Blackman J.D., Pugh W.L., Druetzler A.F., Lukens J.R., Getz G.S., Polonsky K.S. Postprandial triglyceride response in type 1 diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement. Diabetologia. 34:1991;253-259.
40. Bhatnagar D., Durrington P.N., Channon K.M., Prais H., Mackness M.L. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiograph evidence of coronary artery disease. Atherosclerosis. 98:1993;25-32.
41. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke A, Lie K, Kastelein JP for the Regression Growth Evaluation Statin Study Group. A role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis, N Engl J Med 1998;338:86-93.
42. Bernard S., Moulin P., Lagost L., Picard S., Elchebly M., Ponsin G., Chapuis F., Berthezene F. Association between plasma HDL cholesterol concentration and Taq 1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J. Lipid Res. 39:1998;59-65.
43. Grosskope I., Ringel Y., Charach G., Maharshak N., Mor R., Iaina A., Weintraub M. Metformin enhances clearance of chylomicrons and chylomicron remnants in non-diabetic mildly overweight glucose intolerant subjects. Diabetes Care. 20:1997;1598-1602.